Amaranth Medical Reports Findings from Two FORTITUDE Bioresorbable Scaffold Studies at EuroPCR 2015
May 18, 2015 15:12 ET
|
Amaranth Medical, Inc.
Mountain View, CA, May 18, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a
privately held medical device company, announced plans to report
clinical results from the Company's ongoing trial of...
TissueGen Enhances Intellectual Property Portfolio With New Patent for Self-Expanding Medical Device
April 29, 2014 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Apr 29, 2014) - TissueGen® Inc., developer of cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic...
VENITI, Inc. Announces First Uses of Veniti Vici Venous Stent System
January 23, 2014 17:07 ET
|
VENITI, Inc.
ST. LOUIS, Jan. 23, 2014 (GLOBE NEWSWIRE) -- VENITI announced today that patients in the European Union (EU) were successfully treated for symptomatic venous outflow obstruction of the lower...
Amaranth Medical Announces Investment from Boston Scientific
January 14, 2014 09:14 ET
|
Amaranth Medical, Inc.
Mountain View, CA, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, today
announced the closing of an equity investment by Boston Scientific
Corporation...
2012 Deep Research Report on Global and China Coronary Stent Industry
November 12, 2013 09:19 ET
|
Research and Markets
Dublin, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/zt55qc/2012_deep)
has announced the addition of the "2012
Deep Research Report on Global and...
Amaranth Medical Reports Positive Safety and Feasibility Findings for the FORTITUDE(TM) Bioresorbable Scaffold
October 28, 2013 08:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company,
presented positive six-month angiographic results from its
first-in-human study...
Amaranth Medical Raises $20 Million in Series B to Support Development of the FORTITUDE(tm) Bioresorbable Scaffold
October 07, 2013 20:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company,
announced the closing of a $20 million Series B financing led by
new investor DCP...
Alameda County Medical Center Earns Important Cardiac Designation
December 11, 2012 13:30 ET
|
Alameda Health System
OAKLAND, Calif., Dec. 11, 2012 (GLOBE NEWSWIRE) -- Alameda County Medical Center (ACMC www.acmedctr.org), a leading public health care provider, was designated a STEMI Receiving Center (SRC) and...
Biodegradable Stent Safe for Long-Term Treatment of Coronary Artery Disease
April 16, 2012 16:00 ET
|
American Heart Association
Study Highlights:
The first fully biodegradable stent inserted into humans proved safe in a 10-year study.
Major cardiac complication rates were similar to rates of non-biodegradable stents...
Drug-Eluting Balloons are a Promising Tool in Treatment of Narrowed Metal Stents and in Patients at High Risk for Bleeding Complications
November 16, 2011 09:00 ET
|
American Heart Association
Study Highlights:
Drug-releasing balloons are effective in treating restenosis in bare metal stents.
The drug-eluting balloon may also help people at high risk for bleeding complications...